Expanding the eligibility criteria for drugs in Canada's time-limited health technology assessment and temporary drug access processes will further accelerate access to new medicines.

IF 2.9 4区医学 Q2 PHARMACOLOGY & PHARMACY

Journal of Pharmacy and Pharmaceutical Sciences Pub Date : 2024-10-08 eCollection Date: 2024-01-01 DOI:10.3389/jpps.2024.13694

Allison Wills

引用次数: 0

查看原文本刊更多论文

扩大加拿大有时限的卫生技术评估和临时药品使用程序中的药品资格标准，将进一步加快新药的使用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Pharmacy and Pharmaceutical Sciences 医学-药学

CiteScore

6.90

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： The Journal of Pharmacy and Pharmaceutical Sciences (JPPS) is the official journal of the Canadian Society for Pharmaceutical Sciences. JPPS is a broad-spectrum, peer-reviewed, international pharmaceutical journal circulated electronically via the World Wide Web. Subscription to JPPS is free of charge. Articles will appear individually as soon as they are accepted and are ready for circulation.